OCCLLTD
OCCL Limited
OCCL Limited (OCCLLTD) financial statements and selected valuation metrics through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Commodity Chemicals
occlindia.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
OCCL makes insoluble sulphur, which it sells to tyre companies in India and overseas, and also makes sulphuric acid.
Company snapshot
15thBy market cap
Ranked among 24 companies in Commodity Chemicals.
What we see
- ✓Debt-to-equity of 0.20x — the company is largely funded by its own money, not borrowed funds.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 103 Cr | 96 Cr | 107 Cr | 123 Cr | 120 Cr | 114 Cr | 149 Cr | 220 Cr |
| Operating expenses (approx.) | 85 Cr | 80 Cr | 89 Cr | 97 Cr | 100 Cr | 94 Cr | 125 Cr | 158 Cr |
| EBITDA | 19 Cr | 16 Cr | 19 Cr | 26 Cr | 19 Cr | 20 Cr | 24 Cr | 62 Cr |
| OPM % | 18.0% | 16.4% | 17.4% | 21.4% | 16.1% | 17.3% | 16.0% | 28.1% |
| Other income | 0.81 Cr | 0.28 Cr | 0.98 Cr | 0.40 Cr | 0.98 Cr | 0.45 Cr | 0.53 Cr | 2 Cr |
| Interest | 2 Cr | 2 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 2 Cr |
| Depreciation | 7 Cr | 7 Cr | 7 Cr | 7 Cr | 7 Cr | 7 Cr | 7 Cr | 7 Cr |
| Profit before tax | 10 Cr | 7 Cr | 11 Cr | 18 Cr | 12 Cr | 8 Cr | 17 Cr | 54 Cr |
| Tax % | 25.7% | 26.3% | 23.6% | 28.4% | 24.8% | 23.2% | -13.3% | 25.2% |
| Net profit | 8 Cr | 5 Cr | 9 Cr | 13 Cr | 9 Cr | 7 Cr | 19 Cr | 40 Cr |
| EPS (₹) | ₹1.50 | ₹1.05 | ₹1.74 | ₹2.63 | ₹1.74 | ₹1.31 | ₹3.87 | ₹8.06 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 307 Cr | 506 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 254 Cr | 417 Cr | Sign in free for the trailing twelve months |
| EBITDA | 53 Cr | 89 Cr | Sign in free for the trailing twelve months |
| OPM % | 17.3% | 17.6% | Sign in free for the trailing twelve months |
| Other income | 2 Cr | 2 Cr | Sign in free for the trailing twelve months |
| Interest | 5 Cr | 5 Cr | Sign in free for the trailing twelve months |
| Depreciation | 21 Cr | 29 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 29 Cr | 55 Cr | Sign in free for the trailing twelve months |
| Tax % | 25.1% | 14.0% | Sign in free for the trailing twelve months |
| Net profit | 21 Cr | 48 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹4.29 | ₹9.55 | Sign in free for the trailing twelve months |
| Dividend payout % | 0.0% | 26.2% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 10 Cr | 10 Cr |
| Reserves | 386 Cr | 421 Cr |
| Borrowings | 56 Cr | 84 Cr |
| Other liabilities | 82 Cr | 86 Cr |
| Total liabilities | 534 Cr | 602 Cr |
| Fixed assets (net) | 378 Cr | 363 Cr |
| CWIP | 3 Cr | 2 Cr |
| Investments | 11 Cr | 14 Cr |
| Loans & advances | 1 Cr | 0.82 Cr |
| Inventories | 60 Cr | 94 Cr |
| Trade receivables | 65 Cr | 85 Cr |
| Cash & bank | 0.21 Cr | 4 Cr |
| Other assets | 16 Cr | 39 Cr |
| Total assets | 534 Cr | 602 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operating activity | 70 Cr | 11 Cr |
| Cash from investing | -26 Cr | -17 Cr |
| Cash from financing | -44 Cr | 10 Cr |
| Net cash flow | 0.15 Cr | 4 Cr |
| Free cash flow (OCF − Capex) | 57 Cr | -5 Cr |
Ratios
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | 7.5% | 11.7% |
| ROE % | 5.4% | 11.1% |
| Debtor days | 77 | 61 |
| Inventory days | 186 | 138 |
| Days payable | 73 | 40 |
| Cash conversion cycle | 190 | 159 |
| OCF / EBITDA % | 131.8% | 12.4% |
| Debt / equity | 0.14 | 0.20 |
| Current ratio | 1.87 | 1.81 |
| Net debt / EBITDA | 1.06 | 0.90 |